Sponsor study identifier
interventional
130
1 country
3
Study Start
August 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
July 2013
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
July 2016
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The purpose of this trial is to find out the appropriate way to treat DM patients with critical limb ischemia. This trial includes two parts. Part I focuses on the treatment of femoral arterial lesion and part II focuses on the treatment of below-knee arterial lesion.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 2016
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 28, 2010
Actual (reported)July 30, 2010
Actual (reported)August 2010
Date type not reportedThis date has not been verified as actual or estimated.
July 2013
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
July 2016
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Occlusion of the below-knee artery or bypass
36 months
Mortality
30 days
Rate of limb salvage
36 months
Procedural complications, defined as any adverse event
36 months
Quality of Life assessment
36 months
Restenosis measured by Duplex Ultrasound or CTA
36 months
The patients with short-obstruction in the below-knee artery will be included in this group.
The patients with long-obstruction in the below-knee artery will be included in this group.
Before operation, take aspirin 100mg every day. During the operation, balloon is delivered by a catheter and positioned through the narrowing in the artery. Then expand the balloon against the wall of the blood vessel to provide a wider channel for blood.
Before operation, take aspirin 100mg every day. Perform bypass to below-knee(posterior tibial，anterior tibial or peroneal)arteries, saphenous vein graft with end to side anastomoses
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100032, China
Xuanwu Hospital, Beijing
Beijing, Beijing Municipality, 100053, China
Beijing Tongren Hospital
Beijing, Beijing Municipality, Beijing, China
Liu changwei, bachelor
First Submitted
July 28, 2010
First Posted
July 30, 2010
Study Start
August 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
July 2013
Estimated (date passed)Pharmaceutical Care of Patients With Impaired Mobility in a Model-region of Decreasing Supply of Medical Services
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
July 2016
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
December 24, 2012
Record last verified: 2010-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: